CORONARY ANGIOPLASTY AFTER RECOMBINANT TISSUE-TYPE PLASMINOGEN-ACTIVATOR IN ACUTE MYOCARDIAL-INFARCTION - A REPORT FROM THE THROMBOLYSIS IN MYOCARDIAL-INFARCTION (TIMI) TRIAL

被引:15
|
作者
WILLIAMS, DO
RUOCCO, NA
FORMAN, S
机构
关键词
D O I
10.1016/S0735-1097(87)80428-X
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:B45 / B50
页数:6
相关论文
共 50 条
  • [31] DIFFERENT FIBRINOLYTIC POTENCIES OF 2 FORMS OF RECOMBINANT TISSUE-TYPE PLASMINOGEN-ACTIVATOR - NHLBI THROMBOLYSIS IN MYOCARDIAL-INFARCTION TRIAL
    MUELLER, HS
    [J]. CLINICAL RESEARCH, 1986, 34 (02): : A631 - A631
  • [32] RANDOMIZED TRIAL OF INTRAVENOUS RECOMBINANT TISSUE-TYPE PLASMINOGEN-ACTIVATOR VERSUS INTRAVENOUS STREPTOKINASE IN ACUTE MYOCARDIAL-INFARCTION
    VERSTRAETE, M
    BORY, M
    COLLEN, D
    ERBEL, R
    LENNANE, RJ
    MATHEY, D
    MICHELS, HR
    SCHARTL, M
    UEBIS, R
    BERNARD, R
    BROWER, RW
    DEBONO, DP
    HUHMANN, W
    LUBSEN, J
    MEYER, J
    RUTSCH, W
    SCHMIDT, W
    VONESSEN, R
    [J]. LANCET, 1985, 1 (8433): : 842 - 847
  • [33] ARRHYTHMIAS AFTER RECOMBINANT TISSUE PLASMINOGEN-ACTIVATOR IN PATIENTS WITH ACUTE MYOCARDIAL-INFARCTION
    MCNEILL, AJ
    CUNNINGHAM, SR
    SHANNON, JS
    CAMPBELL, NPS
    KHAN, MM
    PATTERSON, GC
    WEBB, SW
    ADGEY, AAJ
    [J]. BRITISH HEART JOURNAL, 1988, 59 (01): : 136 - 137
  • [34] PHARMACODYNAMICS OF THROMBOLYSIS WITH RECOMBINANT TISSUE-TYPE PLASMINOGEN-ACTIVATOR - CORRELATION WITH CHARACTERISTICS OF AND CLINICAL OUTCOMES IN PATIENTS WITH ACUTE MYOCARDIAL-INFARCTION
    STUMP, DC
    CALIFF, RM
    TOPOL, EJ
    SIGMON, K
    THORNTON, D
    MASEK, R
    ANDERSON, L
    COLLEN, D
    [J]. CIRCULATION, 1989, 80 (05) : 1222 - 1230
  • [35] FINAL REPORT OF A RANDOMIZED, PLACEBO-CONTROLLED TRIAL OF INTRAVENOUS RECOMBINANT TISSUE-TYPE PLASMINOGEN-ACTIVATOR AND EMERGENCY CORONARY ANGIOPLASTY THERAPY FOR ACUTE MYOCARDIAL-INFARCTION
    TOPOL, EJ
    ONEILL, WW
    LANGBURD, AB
    BATES, ER
    BOURDILLON, PDV
    WALTON, JA
    GRINES, CL
    KLINE, E
    PITT, B
    [J]. CIRCULATION, 1986, 74 (04) : 22 - 22
  • [36] ONE-YEAR OUTCOME AFTER THERAPY WITH TISSUE PLASMINOGEN-ACTIVATOR - REPORT FROM THE THROMBOLYSIS AND ANGIOPLASTY IN MYOCARDIAL-INFARCTION TRIAL
    CALIFF, RM
    TOPOL, EJ
    GEORGE, BS
    KEREIAKES, DJ
    ARONSON, LG
    LEE, KL
    MARTIN, L
    CANDELA, R
    ABBOTTSMITH, C
    ONEILL, WW
    PRYOR, DB
    STACK, RS
    [J]. AMERICAN HEART JOURNAL, 1990, 119 (04) : 777 - 785
  • [37] USEFULNESS OF LATE CORONARY THROMBOLYSIS (RECOMBINANT TISSUE-TYPE PLASMINOGEN-ACTIVATOR) IN PRESERVING LEFT-VENTRICULAR FUNCTION IN ACUTE MYOCARDIAL-INFARCTION
    VILLARI, B
    PISCIONE, F
    BONADUCE, D
    GOLINO, P
    LANZILLO, T
    CONDORELLI, M
    CHIARIELLO, M
    [J]. AMERICAN JOURNAL OF CARDIOLOGY, 1990, 66 (19): : 1281 - 1286
  • [38] EFFECT OF INTRAVENOUS THERAPY WITH RECOMBINANT TISSUE PLASMINOGEN-ACTIVATOR ON PLASMA-FIBRINOGEN AND THE FIBRINOLYTIC SYSTEM IN PATIENTS WITH ACUTE MYOCARDIAL-INFARCTION - A REPORT FROM THE THROMBOLYSIS IN MYOCARDIAL-INFARCTION TRIAL
    RAO, AK
    [J]. CLINICAL RESEARCH, 1985, 33 (02): : A219 - A219
  • [40] RECOMBINANT TISSUE PLASMINOGEN-ACTIVATOR IN THE EARLY PHASE OF ACUTE MYOCARDIAL-INFARCTION
    MCNEILL, AJ
    SHANNON, JS
    CUNNINGHAM, SR
    FLANNERY, DJ
    CAMPBELL, NPS
    KHAN, MM
    PATTERSON, GC
    WEBB, SW
    ADGEY, AAJ
    [J]. BRITISH HEART JOURNAL, 1987, 57 (06): : 582 - 583